Andrew Cha, DO
Vascular Surgery · Westfield, NJNPI 1568780500
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 185 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,847 and has fallen 68.9% since, to $885 in 2025.
Across 185 payments — averaging $67.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardiovascular Systems Inc.$2K
- W. L. Gore & Associates, Inc.$2K
- Medtronic$1K
- Penumbra, Inc.$967
- Silk Road Medical, Inc.$807
- Bolton Medical Inc$780
- plus $5K from 26 others
What the payments were for
- Travel & lodging$4614%
- Food & beverage$12,05696%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardiovascular Systems Inc. | 31 | $1,984 |
| W. L. Gore & Associates, Inc. | 24 | $1,828 |
| Medtronic(2 entities) | 23 | $1,407 |
| Penumbra, Inc. | 9 | $967 |
| Silk Road Medical, Inc. | 10 | $807 |
| Bolton Medical Inc | 6 | $780 |
| Inari Medical, Inc. | 9 | $769 |
| Limflow Inc. | 3 | $529 |
| Bard Peripheral Vascular, Inc. | 4 | $464 |
| Boston Scientific | 6 | $348 |
| Cook Medical LLC | 3 | $296 |
| Endologix LLC | 2 | $254 |
| Cagent Vascular Inc | 3 | $225 |
| Tactile Systems Technology Inc | 5 | $210 |
| Angiodynamics, Inc. | 3 | $208 |
| Acera Surgical, Inc. | 2 | $167 |
| EKOS Corporation | 2 | $160 |
| Lemaitre Vascular, Inc. | 7 | $152 |
| Shockwave Medical, Inc | 2 | $148 |
| Abbott | 4 | $136 |
| Johnson & Johnson | 8 | $109 |
| Convatec Inc. | 2 | $100 |
| KCI USA, Inc. | 1 | $84 |
| Smith+Nephew | 2 | $82 |
| Pfizer | 5 | $77 |
| Cvrx, Inc. | 1 | $75 |
| Stryker | 2 | $47 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $42 |
| Davol Inc. | 1 | $20 |
| Acell, Inc. | 1 | $14 |
| Cashflow Solutions, LLC | 1 | $13 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Diamondback Peripheral$948
- GORE VIABAHN VBX Balloon Expandable Endo$774
- Indigo System$685
- FLOWTRIEVER CATHETER, S$644
- CT THROMBECTOMY SYSTEM KIT$644
- LIMFLOW SYSTEM$529
- ENROUTE Transcarotid Neuroprotection System$461
- ENROUTE Transcarotid Stent System$461
- ENHANCE Transcarotid Peripheral Access Kit$461
- ENROUTE 0.014 Guidewire$461
- VIABAHN VBX Balloon Expandable Endoprosthesis$389
- TREO ABDOMINAL STENT-GRAFT SYSTEM$296
- Diamondback Coronary$290
- Grafts$288
- HawkOne$230
- IN.PACT Admiral$225
- SpiderFX$194
- GORE TAG Thoracic Branch Endoprosthesis$192
- Valiant Navion$164
- Restrata Wound Matrix$153
How this compares
$12,517 in reported general payments places this provider in the 70th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 20 | $15,678 |
| EliquisApixaban | 12 | $6,781 |
| ClopidogrelClopidogrel Bisulfate | 63 | $814 |
| Atorvastatin Calcium | 13 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $109 | $15,67820 claims |
| PfizerEliquis | $77 | $6,78112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 182 vascular surgery providers in New Jersey.
Other vascular surgery in Westfield
- Scott SundickWestfield$26K
- Salvador CuadraWestfield$12K
- Clifford SalesWestfield$11K
- Steven EliasEnglewood$509K
- Michael WildermanHackensack$383K
- David O'ConnorHackensack$272K
- Joseph LombardiPomona$266K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.